Developer docs
API playgroundTry for free, no card

Search company profiles

Southeastern Endocrine and Diabetes

Full company profile

uuid0027ecl

Namestring
Southeastern Endocrine and Diabetes
Legal namestring
Southeastern Endocrine & Diabetes, P.C.
Websiteurl
seedreed.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Southeastern Endocrine & Diabetes, P.C. (SEED) is a privately held professional corporation operating a single endocrinology and internal medicine practice from its headquarters at 1475 Holcomb Bridge Road, Suite 129, in Roswell, Georgia. The practice is led by Dr. John Chip H. Reed, III, who is board-certified in Internal Medicine and Endocrinology & Metabolism by the American Board of Internal Medicine, and serves patients with diabetes and other endocrine disorders. Its service offering combines direct patient consultations, a structured weekend Diabetes School patient-education program staffed by a multidisciplinary team (including a dietician, diabetes educator, nurse practitioner, endocrinologist, podiatrist, and pharmacist), and clinical trial enrollment through its wholly-owned subsidiary Endocrine Research Solutions, Inc., which conducts FDA-approved studies under independent IRB oversight.

The underlying technology stack is conventional community-practice IT: an eClinicalWorks patient portal for records, scheduling, and messaging; downloadable PDF patient forms; an online bill-pay partner; and integrations with five pump and continuous glucose monitor data-sharing platforms (Medtronic CareLink, Tandem t:connect, Glooko for Omnipod, LibreView, and Dexcom Clarity). The practice does not develop proprietary software; it consumes third-party device and EHR products.

Revenue is generated through standard fee-for-service medical billing to insurers and patients, supplemented by pharmaceutical-sponsored clinical trial per-patient payments via Endocrine Research Solutions, where participants receive medication and medical expenses at no cost. Go-to-market is overwhelmingly local and referral-driven, supported by the practice website (seedreed.com), the Diabetes School as a patient-acquisition funnel, and a Facebook page maintained by the research subsidiary. The practice is HIPAA-compliant as a regulatory baseline; it holds no disclosed patents, no external funding, no parent company, and operates only one physical site serving the southeastern United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersRoswell, United States
HQ citystring
Roswell
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
endocrinology services, diabetes care, diabetes patient education, internal medicine practice, clinical research trials
Industry1 code
1Diabetes (General)
CodeHLAKADAAPrimaryYes
NAICS code1 code
  • Offices of Physicians6211
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Endocrinology and Diabetes Care
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Southeastern Endocrine and Diabetes, P.C. is a physician-led medical practice that diagnoses and treats diabetes and other endocrine disorders at a single office in Roswell, Georgia. The practice augments direct patient care with a weekend Diabetes School education program staffed by a multidisciplinary team and with FDA-approved clinical trials run through its wholly owned subsidiary, Endocrine Research Solutions, Inc.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Southeastern Endocrine and Diabetes, P.C. is a medical practice providing specialized endocrinology and diabetes care. The practice operates a single unified service offering centered on direct patient medical care, augmented by the Diabetes School patient education program, the Endocrine Research Solutions clinical trials division, a downloadable patient forms library, and online services including bill pay and an eClinicalWorks patient portal. These components are not separate software products or technology platforms — the practice does not offer a product-as-a-service architecture with modules or tiers.

Product and service3 records
1Endocrinology and Diabetes Medical Practice
CategoryEndocrinology and Diabetes Medical Services
Description

Physician-led specialist medical care for diabetes and other endocrine disorders, including diagnosis, treatment, insulin management, and ongoing patient follow-up at the Roswell, Georgia office.

2Diabetes School
CategoryPatient Education Program
Description

A weekend patient education program for diabetes patients and their families, covering carbohydrate counting, insulin adjustment, oral agents, exercise, foot care, pumps, meters, complications, and research; classes are taught by a multidisciplinary team including a dietician, diabetes educator, nurse practitioner, endocrinologist, podiatrist, and pharmacist.

3Endocrine Research Solutions, Inc. (Clinical Trials)
CategoryClinical Research Services
Description

Wholly owned clinical research division that conducts FDA-approved pharmaceutical clinical trials for new endocrinology and diabetes medications at the practice office; eligible participants receive trial-related medical care and study medication at no cost.

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical research department established by the practice to conduct clinical trials at the office. The research is FDA approved and follows strict criteria, reviewed by SEED physicians and an independent Institutional Review Board (IRB). All medical expenses for trial participants including medication are provided at no cost.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Telehealth-first diabetes reversal and management platform that delivers endocrinology and diabetes care remotely. Comparable in clinical focus on type 2 diabetes management but uses a virtual care model competing for the same patient demand.

TypeEmerging player
Description

Virtual diabetes and chronic condition management company providing telehealth endocrinology and coaching services. Overlaps with SEED's diabetes education mission but delivers it via a scalable, technology-enabled model.

TypeBroad incumbent
Description

Endocrinology services line of a large Atlanta-area health system offering diabetes and endocrine care within an integrated delivery network. Competes for the same patient pool but with much broader scale and employed-physician model.

TypeOthers
Description

Insulin pump manufacturer whose t:connect platform is integrated into SEED's device data sharing stack. A device ecosystem partner that influences which patients seek care at tech-forward endocrinology practices.

TypeDirect peer
Description

An independent endocrinology and diabetes specialty practice serving the Atlanta metro area. Highly comparable to SEED in patient focus, specialty mix, and private-practice model in the same regional market.

TypeOthers
Description

Leading continuous glucose monitoring (CGM) manufacturer whose Clarity platform is integrated into SEED's data sharing ecosystem. Not a competitor, but a key device partner and supplier shaping the practice's clinical workflow.

7Atlanta Endocrine Associates
TypeDirect peer
Description

Specialist endocrinology group practice in the Atlanta metro providing diabetes and endocrine disorder care. Directly comparable in clinical scope and independent private-practice delivery model.

TypeOthers
Description

Major insulin pump and CGM manufacturer whose CareLink Personal platform is integrated by SEED. An enabler/ecosystem partner rather than a competitor, but its commercial decisions directly affect SEED's pump-using patients.

TypeBroad incumbent
Description

Academic endocrinology division of Emory Healthcare in the Atlanta metro, offering specialty diabetes and endocrine services within a major academic medical center. Competes for complex endocrinology referrals at significantly larger scale.

TypeBroad incumbent
Description

Endocrinology specialty services operated by Wellstar Health System, a major regional health system serving the greater Atlanta area. Overlapping patient population but delivered through a multi-hospital system rather than an independent practice.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Southeastern Endocrine and Diabetes

Endocrinology and Diabetes Careseedreed.com

What Southeastern Endocrine and Diabetes does

Southeastern Endocrine & Diabetes, P.C. (SEED) is a privately held professional corporation operating a single endocrinology and internal medicine practice from its headquarters at 1475 Holcomb Bridge Road, Suite 129, in Roswell, Georgia. The practice is led by Dr. John Chip H. Reed, III, who is board-certified in Internal Medicine and Endocrinology & Metabolism by the American Board of Internal Medicine, and serves patients with diabetes and other endocrine disorders. Its service offering combines direct patient consultations, a structured weekend Diabetes School patient-education program staffed by a multidisciplinary team (including a dietician, diabetes educator, nurse practitioner, endocrinologist, podiatrist, and pharmacist), and clinical trial enrollment through its wholly-owned subsidiary Endocrine Research Solutions, Inc., which conducts FDA-approved studies under independent IRB oversight.

The underlying technology stack is conventional community-practice IT: an eClinicalWorks patient portal for records, scheduling, and messaging; downloadable PDF patient forms; an online bill-pay partner; and integrations with five pump and continuous glucose monitor data-sharing platforms (Medtronic CareLink, Tandem t:connect, Glooko for Omnipod, LibreView, and Dexcom Clarity). The practice does not develop proprietary software; it consumes third-party device and EHR products.

Revenue is generated through standard fee-for-service medical billing to insurers and patients, supplemented by pharmaceutical-sponsored clinical trial per-patient payments via Endocrine Research Solutions, where participants receive medication and medical expenses at no cost. Go-to-market is overwhelmingly local and referral-driven, supported by the practice website (seedreed.com), the Diabetes School as a patient-acquisition funnel, and a Facebook page maintained by the research subsidiary. The practice is HIPAA-compliant as a regulatory baseline; it holds no disclosed patents, no external funding, no parent company, and operates only one physical site serving the southeastern United States.

Southeastern Endocrine and Diabetes firmographics

Firmographics
Name
Southeastern Endocrine and Diabetes
Legal name
Southeastern Endocrine & Diabetes, P.C.
Website
https://seedreed.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Southeastern Endocrine and Diabetes industry classification

Industry
Product category
Endocrinology and Diabetes Care
NAICS
Offices of Physicians (6211)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Diabetes (General) (HLAKADAA)

Keywords

  • Endocrinology services
  • Diabetes care
  • Diabetes patient education
  • Internal medicine practice
  • Clinical research trials

Where Southeastern Endocrine and Diabetes is headquartered

Location

Headquarters

HQ city
Roswell
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Southeastern Endocrine and Diabetes business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Others

Distribution channels2 records

Marketing channels3 records

Southeastern Endocrine and Diabetes product offering

Product offering

Core offering

Southeastern Endocrine and Diabetes, P.C. is a physician-led medical practice that diagnoses and treats diabetes and other endocrine disorders at a single office in Roswell, Georgia. The practice augments direct patient care with a weekend Diabetes School education program staffed by a multidisciplinary team and with FDA-approved clinical trials run through its wholly owned subsidiary, Endocrine Research Solutions, Inc.

Product overview

Southeastern Endocrine and Diabetes, P.C. is a medical practice providing specialized endocrinology and diabetes care. The practice operates a single unified service offering centered on direct patient medical care, augmented by the Diabetes School patient education program, the Endocrine Research Solutions clinical trials division, a downloadable patient forms library, and online services including bill pay and an eClinicalWorks patient portal. These components are not separate software products or technology platforms — the practice does not offer a product-as-a-service architecture with modules or tiers.

Differentiator

Problem solved

Functional benefit

Products and services

  • Endocrinology and Diabetes Medical Practice Physician-led specialist medical care for diabetes and other endocrine disorders, including diagnosis, treatment, insulin management, and ongoing patient follow-up at the Roswell, Georgia office.
  • Diabetes School A weekend patient education program for diabetes patients and their families, covering carbohydrate counting, insulin adjustment, oral agents, exercise, foot care, pumps, meters, complications, and research; classes are taught by a multidisciplinary team including a dietician, diabetes educator, nurse practitioner, endocrinologist, podiatrist, and pharmacist.
  • Endocrine Research Solutions, Inc. (Clinical Trials) Wholly owned clinical research division that conducts FDA-approved pharmaceutical clinical trials for new endocrinology and diabetes medications at the practice office; eligible participants receive trial-related medical care and study medication at no cost.

Companies that use Southeastern Endocrine and Diabetes

Customer profile

Segments1 record

Ideal customer profiles1 record

Southeastern Endocrine and Diabetes technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Southeastern Endocrine and Diabetes partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Endocrine Research Solutions, Inc.coreStrategic or Co-development PartnerClinical research department established by the practice to conduct clinical trials at the office. The research is FDA approved and follows strict criteria, reviewed by SEED physicians and an independent Institutional Review Board (IRB). All medical expenses for trial participants including medication are provided at no cost.

Recent moves5 records

Expansion highlights4 records

Southeastern Endocrine and Diabetes competitors and assessment

Company assessment

Emerging players

  • Virta Health: Telehealth-first diabetes reversal and management platform that delivers endocrinology and diabetes care remotely. Comparable in clinical focus on type 2 diabetes management but uses a virtual care model competing for the same patient demand.
  • Cecelia Health (formerly Fit4D): Virtual diabetes and chronic condition management company providing telehealth endocrinology and coaching services. Overlaps with SEED's diabetes education mission but delivers it via a scalable, technology-enabled model.

Broad incumbents

  • Northside Hospital Endocrinology: Endocrinology services line of a large Atlanta-area health system offering diabetes and endocrine care within an integrated delivery network. Competes for the same patient pool but with much broader scale and employed-physician model.
  • Emory Endocrinology: Academic endocrinology division of Emory Healthcare in the Atlanta metro, offering specialty diabetes and endocrine services within a major academic medical center. Competes for complex endocrinology referrals at significantly larger scale.
  • Wellstar Endocrinology: Endocrinology specialty services operated by Wellstar Health System, a major regional health system serving the greater Atlanta area. Overlapping patient population but delivered through a multi-hospital system rather than an independent practice.

Others

  • Tandem Diabetes Care: Insulin pump manufacturer whose t:connect platform is integrated into SEED's device data sharing stack. A device ecosystem partner that influences which patients seek care at tech-forward endocrinology practices.
  • Dexcom: Leading continuous glucose monitoring (CGM) manufacturer whose Clarity platform is integrated into SEED's data sharing ecosystem. Not a competitor, but a key device partner and supplier shaping the practice's clinical workflow.
  • Medtronic Diabetes: Major insulin pump and CGM manufacturer whose CareLink Personal platform is integrated by SEED. An enabler/ecosystem partner rather than a competitor, but its commercial decisions directly affect SEED's pump-using patients.

Direct peers

  • Atlanta Diabetes Associates: An independent endocrinology and diabetes specialty practice serving the Atlanta metro area. Highly comparable to SEED in patient focus, specialty mix, and private-practice model in the same regional market.
  • Atlanta Endocrine Associates: Specialist endocrinology group practice in the Atlanta metro providing diabetes and endocrine disorder care. Directly comparable in clinical scope and independent private-practice delivery model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Southeastern Endocrine and Diabetes social profiles

Digital presence

Southeastern Endocrine and Diabetes compliance and trust

Trust signal

Compliance1 record

Southeastern Endocrine and Diabetes financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Southeastern Endocrine and Diabetes leadership team

Management profile

Number of profiles

Profiles1 record

Southeastern Endocrine and Diabetes subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Southeastern Endocrine and Diabetes funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Southeastern Endocrine and Diabetes M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Southeastern Endocrine and Diabetes

What does Southeastern Endocrine and Diabetes do?

Southeastern Endocrine and Diabetes, P.C. is a physician-led medical practice that diagnoses and treats diabetes and other endocrine disorders at a single office in Roswell, Georgia. The practice augments direct patient care with a weekend Diabetes School education program staffed by a multidisciplinary team and with FDA-approved clinical trials run through its wholly owned subsidiary, Endocrine Research Solutions, Inc.

Is Southeastern Endocrine and Diabetes a public or private company?

Southeastern Endocrine and Diabetes is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Southeastern Endocrine and Diabetes founded?

Southeastern Endocrine and Diabetes was founded in -1. It employs 1 to 10 people.

Where is Southeastern Endocrine and Diabetes based?

Southeastern Endocrine and Diabetes is headquartered in Roswell, United States, in the North America region.

Who are Southeastern Endocrine and Diabetes's main competitors?

Emerging players on record are Virta Health and Cecelia Health (formerly Fit4D). Broad incumbents are Northside Hospital Endocrinology, Emory Endocrinology and Wellstar Endocrinology. Others are Tandem Diabetes Care, Dexcom and Medtronic Diabetes. Direct peers are Atlanta Diabetes Associates and Atlanta Endocrine Associates.

Does Southeastern Endocrine and Diabetes have an API?

No public API is recorded for Southeastern Endocrine and Diabetes.

What industry is Southeastern Endocrine and Diabetes in?

Southeastern Endocrine and Diabetes's product category is Endocrinology and Diabetes Care. Its primary akta.pro industry code is HLAKADAA, Diabetes (General). Its NAICS code is 6211 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales